Cross-presentation by dendritic cells
Publication type: Journal Article
Publication date: 2012-07-13
scimago Q1
wos Q1
SJR: 17.458
CiteScore: 84.7
Impact factor: 60.9
ISSN: 14741733, 14741741
DOI:
10.1038/nri3254
PubMed ID:
22790179
Energy Engineering and Power Technology
Fuel Technology
Abstract
This Review integrates recent evidence regarding the intracellular trafficking pathways involved in cross-presentation into our understanding of the role of cross-presentation in immunity and tolerance. The presentation of exogenous antigens on MHC class I molecules, known as cross-presentation, is essential for the initiation of CD8+ T cell responses. In vivo, cross-presentation is mainly carried out by specific dendritic cell (DC) subsets through an adaptation of their endocytic and phagocytic pathways. Here, we summarize recent advances in our understanding of the intracellular mechanisms of cross-presentation and discuss its role in immunity and tolerance in the context of specialization between DC subsets. Finally, we review current strategies to use cross-presentation for immunotherapy.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
10
20
30
40
50
60
70
80
90
|
|
|
Frontiers in Immunology
83 publications, 6.21%
|
|
|
Journal of Immunology
35 publications, 2.62%
|
|
|
Nature Communications
28 publications, 2.09%
|
|
|
Vaccines
26 publications, 1.94%
|
|
|
Biomaterials
25 publications, 1.87%
|
|
|
Journal of Controlled Release
24 publications, 1.8%
|
|
|
Scientific Reports
20 publications, 1.5%
|
|
|
PLoS ONE
20 publications, 1.5%
|
|
|
OncoImmunology
17 publications, 1.27%
|
|
|
ACS Nano
15 publications, 1.12%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
14 publications, 1.05%
|
|
|
Molecular Immunology
12 publications, 0.9%
|
|
|
Immunological Reviews
12 publications, 0.9%
|
|
|
Pharmaceutics
11 publications, 0.82%
|
|
|
International Journal of Molecular Sciences
11 publications, 0.82%
|
|
|
Cancers
11 publications, 0.82%
|
|
|
Immunity
11 publications, 0.82%
|
|
|
Advanced Drug Delivery Reviews
11 publications, 0.82%
|
|
|
Advanced healthcare materials
11 publications, 0.82%
|
|
|
Nature Reviews Immunology
10 publications, 0.75%
|
|
|
Vaccine
10 publications, 0.75%
|
|
|
Trends in Immunology
10 publications, 0.75%
|
|
|
ACS applied materials & interfaces
9 publications, 0.67%
|
|
|
Current Opinion in Immunology
9 publications, 0.67%
|
|
|
Cell Reports
9 publications, 0.67%
|
|
|
Advanced Materials
9 publications, 0.67%
|
|
|
Biomaterials Science
9 publications, 0.67%
|
|
|
Oncotarget
8 publications, 0.6%
|
|
|
Cells
8 publications, 0.6%
|
|
|
10
20
30
40
50
60
70
80
90
|
Publishers
|
50
100
150
200
250
300
350
|
|
|
Elsevier
321 publications, 24.01%
|
|
|
Springer Nature
210 publications, 15.71%
|
|
|
Wiley
162 publications, 12.12%
|
|
|
Frontiers Media S.A.
119 publications, 8.9%
|
|
|
MDPI
91 publications, 6.81%
|
|
|
Taylor & Francis
60 publications, 4.49%
|
|
|
American Chemical Society (ACS)
58 publications, 4.34%
|
|
|
The American Association of Immunologists
35 publications, 2.62%
|
|
|
Cold Spring Harbor Laboratory
28 publications, 2.09%
|
|
|
Public Library of Science (PLoS)
27 publications, 2.02%
|
|
|
Royal Society of Chemistry (RSC)
25 publications, 1.87%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
14 publications, 1.05%
|
|
|
American Society for Microbiology
11 publications, 0.82%
|
|
|
American Association for Cancer Research (AACR)
10 publications, 0.75%
|
|
|
Annual Reviews
10 publications, 0.75%
|
|
|
Impact Journals
9 publications, 0.67%
|
|
|
Hindawi Limited
9 publications, 0.67%
|
|
|
Oxford University Press
8 publications, 0.6%
|
|
|
BMJ
8 publications, 0.6%
|
|
|
American Association for the Advancement of Science (AAAS)
8 publications, 0.6%
|
|
|
American Society of Hematology
8 publications, 0.6%
|
|
|
Rockefeller University Press
6 publications, 0.45%
|
|
|
American Society for Clinical Investigation
5 publications, 0.37%
|
|
|
Mary Ann Liebert
5 publications, 0.37%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 0.37%
|
|
|
SAGE
5 publications, 0.37%
|
|
|
American Society for Biochemistry and Molecular Biology
4 publications, 0.3%
|
|
|
IntechOpen
3 publications, 0.22%
|
|
|
European Molecular Biology Organization
3 publications, 0.22%
|
|
|
50
100
150
200
250
300
350
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.3k
Total citations:
1337
Citations from 2024:
196
(14.66%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Joffre O. P. et al. Cross-presentation by dendritic cells // Nature Reviews Immunology. 2012. Vol. 12. No. 8. pp. 557-569.
GOST all authors (up to 50)
Copy
Joffre O. P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells // Nature Reviews Immunology. 2012. Vol. 12. No. 8. pp. 557-569.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/nri3254
UR - https://doi.org/10.1038/nri3254
TI - Cross-presentation by dendritic cells
T2 - Nature Reviews Immunology
AU - Joffre, Olivier P
AU - Segura, Elodie
AU - Savina, Ariel
AU - Amigorena, Sebastian
PY - 2012
DA - 2012/07/13
PB - Springer Nature
SP - 557-569
IS - 8
VL - 12
PMID - 22790179
SN - 1474-1733
SN - 1474-1741
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2012_Joffre,
author = {Olivier P Joffre and Elodie Segura and Ariel Savina and Sebastian Amigorena},
title = {Cross-presentation by dendritic cells},
journal = {Nature Reviews Immunology},
year = {2012},
volume = {12},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1038/nri3254},
number = {8},
pages = {557--569},
doi = {10.1038/nri3254}
}
Cite this
MLA
Copy
Joffre, Olivier P., et al. “Cross-presentation by dendritic cells.” Nature Reviews Immunology, vol. 12, no. 8, Jul. 2012, pp. 557-569. https://doi.org/10.1038/nri3254.